Scott A Holmes Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott A Holmes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott A Holmes. Scott A Holmes is a Chief Accounting Officer in AMAG PHARMACEUTICALS INC. ($AVM) and a SVP, Chief Accounting Officer in AMAG PHARMACEUTICALS INC. ($AVM) and a SVP, Finance and Treasurer in AMAG PHARMACEUTICALS INC. ($AVM) and a Chief Financial Officer in KERYX BIOPHARMACEUTICALS INC ($KERX).
Address: C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON 02421 MA
Companies in which Scott A Holmes is an Insider
AMAG PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott A Holmes: SVP, Finance and Treasurer, SVP, Chief Accounting Officer, Chief Accounting Officer
Holdings: 51,958 shares
Latest Transaction: Jun 17 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott A Holmes: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Scott A Holmes
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Option Exercise | D | 0.00 | 902,500 | 0 | 0 | |
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | D | 0.00 | 162,956 | 0 | 0 | 163 K to 0 (-100.00 %) |
| Nov 16 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 2.77 | 1,155 | 3,199 | 162,956 | 164.1 K to 163 K (-0.70 %) |
| Oct 30 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 3.07 | 1,254 | 3,850 | 164,111 | 165.4 K to 164.1 K (-0.76 %) |
| Aug 16 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 3.04 | 1,185 | 3,602 | 165,365 | 166.6 K to 165.4 K (-0.71 %) |
| Jul 31 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 3.86 | 2,354 | 9,086 | 166,550 | 168.9 K to 166.6 K (-1.39 %) |
| May 16 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | S | 5.69 | 1,158 | 6,589 | 168,904 | 170.1 K to 168.9 K (-0.68 %) |